Callan JMB (NASDAQ:CJMB) Releases Quarterly Earnings Results

Callan JMB (NASDAQ:CJMB) posted its quarterly earnings results on Friday. The company reported ($0.59) EPS for the quarter, Zacks reports. Callan JMB had a negative net margin of 139.14% and a negative return on equity of 166.44%.

Callan JMB Stock Up 1.0%

NASDAQ CJMB traded up $0.01 during mid-day trading on Friday, hitting $1.01. The stock had a trading volume of 16,104 shares, compared to its average volume of 105,185. Callan JMB has a 52-week low of $0.86 and a 52-week high of $5.88. The company has a market cap of $5.69 million, a price-to-earnings ratio of -0.56 and a beta of 0.35. The company has a 50 day simple moving average of $1.37 and a 200 day simple moving average of $1.93.

Insiders Place Their Bets

In other news, insider David J. Croyle acquired 14,805 shares of the company’s stock in a transaction that occurred on Friday, March 6th. The stock was purchased at an average cost of $1.76 per share, with a total value of $26,056.80. Following the purchase, the insider directly owned 789,805 shares of the company’s stock, valued at approximately $1,390,056.80. This trade represents a 1.91% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. 73.87% of the stock is owned by insiders.

Hedge Funds Weigh In On Callan JMB

An institutional investor recently raised its position in Callan JMB stock. Creative Planning raised its holdings in shares of Callan JMB Inc. (NASDAQ:CJMB) by 41.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 170,008 shares of the company’s stock after acquiring an additional 50,000 shares during the quarter. Creative Planning owned approximately 3.79% of Callan JMB worth $830,000 as of its most recent filing with the Securities and Exchange Commission.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Callan JMB in a research report on Wednesday, April 29th. Wall Street Zen upgraded shares of Callan JMB to a “hold” rating in a report on Saturday, March 28th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.

Callan JMB Company Profile

Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.